Additionally, inhibiting LAG-3, which regulates immune response and T-cell activity, in conjunction with PD-1 blockade, has shown promise in various cancers, although some research indicates no significant difference in LAG-3 and TIM-3 expression in testicular GCTs compared to normal tissues (387). Here, LAG3 is linked to cancer.